John Televantos, Partner at Arsenal Capital, 2012 Honoree for distinction in private equity.
Since 2006, Dr. Televantos has been with Arsenal Capital Partners where he serves as co-head of the Specialty Industrial practice of the firm with a focus on Specialty Chemicals and Materials. During his tenure with Arsenal he has been part of the acquisitions of Fluoro-Seal, Royal Adhesives & Sealants, Evonik’s Colorants business, and the acquisition and subsequent divestiture to BASF of Novolyte Technologies.
Dr. Televantos is a Partner at Arsenal Capital Partners, a leading middle market Private Equity Firm. Prior to joining Arsenal in 2006, Dr. Televantos was President of Aqualon Company, owned by Hercules Incorporated, President and Founder of Helios Chemical Company, and Chief Executive Officer for Foamex International. John started his career with Union Carbide, in silicones research and worked for ARCO Chemical. For the last 6 years Dr. Televantos has been with Arsenal Capital where he serves as co-head of the Specialty Industrial practice with a focus on Specialty Chemicals and Materials. He has been part of several acquisitions and successful exits in the chemicals and materials sectors of the economy. He has a B.S. and Ph.D. in Chemical Engineering from the University of London, UK. In addition to serving on the Boards of several Arsenal-owned companies he serves on the Board and is lead Director of Balchem Corp (BCPC).